Press releases and news articles
Medical Ethics in the Media
Press releases
May 22, 2018
Australian life sciences company Medical Ethics announce a £3 million investment in Wales
Melbourne-based life science research and development company Medical Ethics has announced a direct investment of over £3 million in Wales over the next three years, making Cardiff its new base in the northern hemisphere. Medical Ethics develop products that alleviate pain and minimise suffering associated with wounds and surgical procedures in animals. As a UK …
November 16, 2017
Tri-Solfen registered in New Zealand for sheep and cattle husbandry procedures
Third registration received for the Group’s innovative pain mitigation product Expanding Tri-Solfen’s commercial potential Melbourne, Australia – 16 November 2017 – Medical Ethics Pty Ltd (“Medical Ethics” or “the Group”), a commercial and development company focused on pain mitigation in wounds for humans and animals, announces that its wholly owned subsidiary, Animal Ethics Pty Ltd …
Continue reading "Tri-Solfen registered in New Zealand for sheep and cattle husbandry procedures"
September 27, 2017
Zanda’s cattle pain relief vision on show
IT’S a matter of seeing is believing. A squirt of the blue gel from the purpose made applicator onto the wounds left by the dehorning, branding or, in the case of bull calves, castration, and the job is done. But it’s the behaviour of those young calves almost immediately after leaping up from the branding …
Continue reading "Zanda’s cattle pain relief vision on show"
April 3, 2017
Australian Research Company Animal Ethics Secures UK investment partner
Animal Ethics Pty Ltd (Animal Ethics) secures cornerstone investor with 33% of its share capital purchased by FTSE 250 company Dechra Pharmaceuticals PLC. The investment includes a global license agreement (excluding Australia and NZ) for the Animal Ethics pain mitigation and wound treatment technology Tri-Solfen®, and will accelerate Animal Ethics objective to register Tri-Solfen® in …
Continue reading "Australian Research Company Animal Ethics Secures UK investment partner"
News articles
May 17, 2022
Tri-Solfen® by Medical Ethics efficient in managing FMD in Cameroon – new scientific paper
Tri-Solfen® by Medical Ethics features in a new scientific paper discussing a study on FMD in Cameroon. A summary (Abstract and Figures) can be found in the Scientific Publications section of this website, here. The original scientific paper 'Foot and Mouth Disease in Cameroon: A Systematic Review to Support its Progressive Control' can be found …
March 31, 2022
New advertising campaign for Tri-Solfen® by Medical Ethics
Troy Setter, CEO of Consolidated Pastoral Company, features in the first of our new advertising campaign for Tri-Solfen. The Campaign is currently running in Queensland Country Life.
March 14, 2022
RSPCA welcome wider availability of Medical Ethics’ Tri-Solfen
Producers can now use the animal pain relief product Tri-Solfen® to improve animal welfare outcomes during dehorning and disbudding procedures in cattle. Applied as a gel and available from rural resellers, Tri-Solfen® was originally registered for relief for sheep post-mulesing. It was later registered for use in cattle at castration. The RSPCA released a statement …
Continue reading "RSPCA welcome wider availability of Medical Ethics’ Tri-Solfen"
December 22, 2021
David Foote: Use pain relief because it works
Article originally published by Queensland Country Life and was written by Mark Phelps. Mark Phelps DAVID Foote says there's one overwhelming reason why producers should be using pain relief on their cattle. "It works," the Australian Country Choice Group director said. "We're using Tri-Solfen and meloxicam as pain relief on all of our calves …
Continue reading "David Foote: Use pain relief because it works"